These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38908646)

  • 1. A novel anti-CD47 protein antibody and toll-like receptor agonist complex detects tumor surface CD-47 changes in early stage lung cancer by in vivo imaging.
    Xu Y; Gu L; Zhu L; Miao Y; Cui X
    Int J Biol Macromol; 2024 Aug; 274(Pt 1):133322. PubMed ID: 38908646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoscale Metal-Organic Framework Co-delivers TLR-7 Agonists and Anti-CD47 Antibodies to Modulate Macrophages and Orchestrate Cancer Immunotherapy.
    Ni K; Luo T; Culbert A; Kaufmann M; Jiang X; Lin W
    J Am Chem Soc; 2020 Jul; 142(29):12579-12584. PubMed ID: 32658476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supermolecular nanovehicles co-delivering TLR7/8-agonist and anti-CD47 siRNA for enhanced tumor immunotherapy.
    Shang T; Yu X; Gu Y; Du R; Cai Y; Li Y; Zheng G; Wang C; Zhang J; Liu J; Han S; Yang B
    Int J Biol Macromol; 2023 Nov; 251():126539. PubMed ID: 37634787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-Functional PLGA Nanoparticles Co-Loaded with Indocyanine Green and Resiquimod for Prostate Cancer Treatment.
    Lin W; Li C; Xu N; Watanabe M; Xue R; Xu A; Araki M; Sun R; Liu C; Nasu Y; Huang P
    Int J Nanomedicine; 2021; 16():2775-2787. PubMed ID: 33880023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor microenvironment-responsive macrophage-mediated immunotherapeutic drug delivery.
    Zhang X; Yue L; Cao L; Liu K; Yang S; Liang S; Liu L; Zhao C; Wu D; Wang Z; Tian R; Rao L
    Acta Biomater; 2024 Sep; 186():369-382. PubMed ID: 39097127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual checkpoint blockade of CD47 and PD-L1 using an affinity-tuned bispecific antibody maximizes antitumor immunity.
    Chen SH; Dominik PK; Stanfield J; Ding S; Yang W; Kurd N; Llewellyn R; Heyen J; Wang C; Melton Z; Van Blarcom T; Lindquist KC; Chaparro-Riggers J; Salek-Ardakani S
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34599020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide-guided resiquimod-loaded lignin nanoparticles convert tumor-associated macrophages from M2 to M1 phenotype for enhanced chemotherapy.
    Figueiredo P; Lepland A; Scodeller P; Fontana F; Torrieri G; Tiboni M; Shahbazi MA; Casettari L; Kostiainen MA; Hirvonen J; Teesalu T; Santos HA
    Acta Biomater; 2021 Oct; 133():231-243. PubMed ID: 33011297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Petaloid Metal-Organic Frameworks for Resiquimod Delivery To Potentiate Antitumor Immunity.
    Zhang C; Deng Z; Sun X; Yuan K; Wang J; Wu X; Zhang Y; Yang K; Zhang J; Yang G
    ACS Appl Mater Interfaces; 2024 Jul; 16(26):33093-33105. PubMed ID: 38884171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted co-delivery of resiquimod and a SIRPα variant by liposomes to activate macrophage immune responses for tumor immunotherapy.
    Jia D; Lu Y; Lv M; Wang F; Lu X; Zhu W; Wei J; Guo W; Liu R; Li G; Wang R; Li J; Yuan F
    J Control Release; 2023 Aug; 360():858-871. PubMed ID: 37473808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Fc Receptor-Mediated Effects and the "Don't Eat Me" Signal with an Oncolytic Virus Expressing an Anti-CD47 Antibody to Treat Metastatic Ovarian Cancer.
    Tian L; Xu B; Teng KY; Song M; Zhu Z; Chen Y; Wang J; Zhang J; Feng M; Kaur B; Rodriguez L; Caligiuri MA; Yu J
    Clin Cancer Res; 2022 Jan; 28(1):201-214. PubMed ID: 34645647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD47-mediated immune evasion in early-stage lung cancer progression.
    Chuang CH; Zhen YY; Ma JY; Lee TH; Hung HY; Wu CC; Wang PH; Huang CT; Huang MS; Hsiao M; Lee YR; Huang CF; Chang YC; Yang CJ
    Biochem Biophys Res Commun; 2024 Aug; 720():150066. PubMed ID: 38749193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy.
    Rodell CB; Arlauckas SP; Cuccarese MF; Garris CS; Li R; Ahmed MS; Kohler RH; Pittet MJ; Weissleder R
    Nat Biomed Eng; 2018 Aug; 2(8):578-588. PubMed ID: 31015631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancer.
    Ye J; Mills BN; Qin SS; Garrett-Larsen J; Murphy JD; Uccello TP; Han BJ; Vrooman TG; Johnston CJ; Lord EM; Belt BA; Linehan DC; Gerber SA
    J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35851308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of Light-Activated Nanoplatform through Boosting "Eat Me" Signals for Improved CD47-Blocking Immunotherapy.
    Lu Y; Gong Y; Zhu X; Dong X; Zhu D; Ma G
    Adv Healthc Mater; 2022 May; 11(10):e2102712. PubMed ID: 34981660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic liposomal combination to enhance chemotherapy response and immune activation of tumor microenvironment.
    Gu Z; Yin J; Da Silva CG; Liu Q; Cruz LJ; Ossendorp F; Snaar-Jagalska E
    J Control Release; 2024 Sep; 373():38-54. PubMed ID: 38986909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activable Nano-Immunomodulator Assembled from π-Extended Naphthalenediimide for Precision Photothermal Immunotherapy.
    Zhong W; Yuan W; Chen Y; Ma Z; Ma M; Tan BSN; Yang J; Zhao Y
    Angew Chem Int Ed Engl; 2024 Jun; 63(23):e202401250. PubMed ID: 38576254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-delivery of metal-coordinated NIR-II nanoadjuvants for multimodal imaging-guided photothermal-chemodynamic amplified immunotherapy.
    Dai Y; Li X; Xue Y; Chen K; Jiao G; Zhu L; Li M; Fan Q; Dai Y; Zhao Q; Shen Q
    Acta Biomater; 2023 Aug; 166():496-511. PubMed ID: 37230439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of cancer vaccine adjuvanted with nanoemulsion loaded with TLR7/8 agonist in lung cancer model.
    Koh J; Kim S; Lee SN; Kim SY; Kim JE; Lee KY; Kim MS; Heo JY; Park YM; Ku BM; Sun JM; Lee SH; Ahn JS; Park K; Yang S; Ha SJ; Lim YT; Ahn MJ
    Nanomedicine; 2021 Oct; 37():102415. PubMed ID: 34174421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymeric nanocapsules loaded with poly(I:C) and resiquimod to reprogram tumor-associated macrophages for the treatment of solid tumors.
    Anfray C; Varela CF; Ummarino A; Maeda A; Sironi M; Gandoy S; Brea J; Loza MI; León S; Calvo A; Correa J; Fernandez-Megia E; Alonso MJ; Allavena P; Crecente-Campo J; Andón FT
    Front Immunol; 2023; 14():1334800. PubMed ID: 38259462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy.
    Schürch CM; Roelli MA; Forster S; Wasmer MH; Brühl F; Maire RS; Di Pancrazio S; Ruepp MD; Giger R; Perren A; Schmitt AM; Krebs P; Charles RP; Dettmer MS
    Thyroid; 2019 Jul; 29(7):979-992. PubMed ID: 30938231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.